NISHABEN PATEL: Open Payments
NPI 1528611365 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 12 payments from 6 companies in 2025. Trend: 2023 $217 · 2024 $199 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
| Vanda Pharmaceuticals Inc. | 3 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
Products named: COBENFY, FANAPT, INVEGA SUSTENNA, INGREZZA, REXULTI, VRAYLAR.
Industry payments across GA — which companies pay providers there.
